STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3331 by analyst upside · 2026-08-13
CAH
Cardinal Health, Inc.
Healthcare · Market Cap $54B · P/E 32.4x
ANALYST PRICE TARGET
+7.8%
implied upside to consensus target
Current Price $234.16
Consensus Target $252.4
Bull Target $275.0
Bear Target $215.0
Analysts Covering 15
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
11
Hold
3
Sell
0
52-Week Low $145.47
52-Week High $258.3
YTD Return +14.3%
FUNDAMENTALS
Market Cap $54B
P/E Ratio (TTM) 32.4x
Forward P/E 16.8x
EPS (TTM) $7.23
PEG Ratio 1.47
Dividend Yield 0.86%
Revenue (TTM) $254.2B
Profit Margin 0.7%
52-WEEK RANGE
52-Week Low $145.47
52-Week High $258.3
Current Price $234.16
Bear Target $215.0
Bull Target $275.0
● Now $234.16 ● Target $252.4
TRADING DATA
Avg Volume 2.3M
YTD Return +14.3%
Analyst Count 15
Consensus Buy
Upside to Target +7.8%
Last Updated 2026-08-13

ANALYST SUMMARY

Cardinal Health, Inc. (CAH) is currently trading at $234.16 with a Wall Street consensus price target of $252.4, implying potential upside of 7.8% over the next 12 months. 15 analysts currently cover CAH, with a consensus rating of Buy - 81% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $275.0, while the most cautious has a target of $215.0.

CAH operates in the Healthcare sector with a market capitalisation of $54B. The stock is up 14.3% year-to-date and is currently trading near the upper end of its 52-week range of $145.47 – $258.3.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CAH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Neutral → Neutral 2026-05-04 43% win rate (7 calls)
Citigroup - Reiterated
Buy → Buy 2026-05-01 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-05-01 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-05-01 Building track record
William Blair ● Initiated
Outperform 2026-04-28 44% win rate (9 calls)
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-08 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-02-24 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-02-10 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
68
out of 100
Coverage depth
21/30
Consensus clarity
25/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →